Search results
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 3 hours agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar ...
Cannabinoids With Chemotherapy For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For...
Benzinga· 31 minutes agoEnveric Biosciences ENVB, a Nasdaq-listed psychedelics biotech firm, has entered into a non-binding term sheet with an undisclosed biotech company (licensee) for an exclusive ...
How does the drug abemaciclib treat breast cancer? - EconoTimes
EconoTimes· 34 minutes agoThe anti-cancer drug abemaciclib (also known as Vernezio) has this month been added to the...
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
Motley Fool via Yahoo Finance· 21 minutes agoThe company raised the payout in late 2023, a sign of confidence in its future. Should you invest...
How sham patents are hurting the pharma industry
Pharmaceutical Technology via Yahoo Finance· 1 day ago“The purpose of the Orange Book process,” says Rohit Singla...and then face patent litigation,” he adds. “If they lost, the generic faces potentially...
Hygrovest increases Net Asset Value per share by 23% to A$0.1355 in April
Proactive Investors· 5 hours ago...due to a 50% increase in the Enterprise Value to Net Revenue Multiple (EV/NRM) used by HGV when...
5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip
Motley Fool via Yahoo Finance· 2 hours agoThe 10 stocks that made the cut could produce monster returns in the coming years. Consider when...
Q1 2024 Abcellera Biologics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 36 minutes agoWe'd also like to congratulate our single bio, who in April, announced the first patient dosed in a Phase one two trial for AB. 21 hundred, which is in development as a treatment for clear cell ...
AstraZeneca pulls Covid vaccine after admitting rare side effect
Daily Express· 12 hours agoThe Oxford-AstraZeneca Covid vaccine is set to be withdrawn after the pharmaceutical giant admitted...
Pfizer Inc's Dividend Analysis
GuruFocus.com via Yahoo Finance· 35 minutes agoPfizer Inc (NYSE:PFE) recently announced a dividend of $0.42 per share, payable on 2024-06-14, with the ex-dividend date set for 2024-05-09. As investors...
